pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
LEADING · news · pharmadog
← back to LEADING
News mentioning LEADING
653
stories
Aug 28, 26
Priovant nabs first FDA approval for targeted tablet in dermatomyositis
biospace
Aug 28, 26
STAT+: In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs
stat
Aug 28, 26
Early Alert: Angiographic Catheter Issue from Boston Scientific
fda medwatch
Aug 27, 26
Gilead gets another HIV treatment approval, extending lenacapavir's dominance
endpoints
Aug 27, 26
FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults
fda press
Aug 27, 26
New data could widen use of AstraZeneca, Amgen immune disease drug
biopharma dive
Aug 27, 26
A year on from Big Pharma’s pull-back from the UK, has anything changed?
fiercebiotech
Aug 27, 26
Lilly's move to hide Phase 1 pipeline draws mixed reviews
endpoints
Aug 27, 26
Chutes & Ladders—Vivace revs up C-suite ahead of pivotal push
fiercebiotech
Aug 27, 26
RFK Jr. said a Samoa trip had nothing to do with vaccines. New documents refute that
stat
Aug 27, 26
Opinion: I studied Reddit forums on menopause — and found what doctors are missing
stat
Aug 26, 26
Vitruvias vanishes amid thyroid tablets recall over potential ‘superpotency’ concerns
biospace
Aug 26, 26
Flagship’s ProFound partners with Gates Foundation in $35M preeclampsia target discovery pact
fiercebiotech
Aug 26, 26
China in Global Clinical Development: Why Early Inclusion Matters
fiercebiotech
Aug 26, 26
Spyre tumbles as immune drug misses mark in rheumatoid arthritis
biopharma dive
Aug 26, 26
On the fence about a statin? In borderline cases, calcium scans could be a tiebreaker
stat
Aug 26, 26
FDA eyes 2 new deputy commissioner posts: Report
biospace
Aug 26, 26
Akeso CEO looks beyond lung cancer with biliary tract win, counters ivonescimab debate
fiercebiotech
Aug 26, 26
Hansoh heralds China’s move from ‘follower’ to ‘frontrunner’ in biopharma race
fiercebiotech
Aug 26, 26
Newer shingles vaccine linked to lower heart disease risk, ‘natural experiment’ shows
stat
Aug 26, 26
STAT+: When it comes to women’s health, money talks
stat
Aug 26, 26
SK Biopharma pens $795M deal to usher Biohaven’s epilepsy therapy towards hoped-for 2029 launch
fiercebiotech
Aug 25, 26
Roche, Eli Lilly get FDA nod for new Alzheimer’s blood test
biopharma dive
Aug 25, 26
J&J’s Imaavy wins label expansion; Two approvals in Japan
endpoints
Aug 25, 26
Will a ‘reset’ reignite investment in women’s health startups?
biopharma dive
Aug 25, 26
Labcorp launches new hepatitis D test to find patients with most severe form of virus
fiercebiotech
Aug 25, 26
How Trump’s cuts are reshaping America’s health system
stat
Aug 25, 26
Opinion: Cancer screening guidelines need to address long-term care facilities
stat
Aug 25, 26
Implantica finally nabs FDA approval 8 years after EU green light for reflux implant
fiercebiotech
Aug 25, 26
Young startups miss out on biotech venture funding rebound, MassBio says
biopharma dive
← prev
page 10 of 22
next →
